In contrast, the conclusion of a study by Mencej-Bedrac et al. is that this polymorphism can be considered a risk factor for genetic susceptibility to postmenopausal osteoporosis while not affecting serum OPG levels [28]. This evidence concerns the gene TNFRSF11B and postmenopausal osteoporosis.